Ignite Creation Date:
2025-12-24 @ 2:33 PM
Ignite Modification Date:
2026-02-03 @ 12:42 AM
Study NCT ID:
NCT04030559
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-08-26
First Post:
2019-07-22
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Niraparib Before Surgery in Treating Patients With High Risk Localized Prostate Cancer and DNA Damage Response Defects
Sponsor:
Marc Dall'Era, MD
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | ATM Gene Mutation | View |
| None | BRCA1 Gene Mutation | View |
| None | BRCA2 Gene Mutation | View |
| None | BRIP1 Gene Mutation | View |
| None | CDK12 Gene Mutation | View |
| None | CHEK1 Gene Mutation | View |
| None | CHEK2 Gene Mutation | View |
| None | DNA Damage Response Gene Mutation | View |
| None | DNA Repair Gene Mutation | View |
| None | FANCA Gene Mutation | View |
| None | FANCD2 Gene Mutation | View |
| None | FANCL Gene Mutation | View |
| None | GEN1 Gene Mutation | View |
| None | NBN Gene Mutation | View |
| None | Prostate Carcinoma | View |
| None | RAD51 Gene Mutation | View |
| None | RAD51C Gene Mutation | View |
Keywords: